Veterinary Diagnostics and Equipment
The Global Market
| Publication Date | January 2006 |
|---|---|
| Publisher | Animal Pharm |
| Product Type | Report |
| Pages | 147 |
| ISBN Number | not applicable |
| Product Code | ANP00015 |
Summary
Within the last decade, a new veterinary devices and diagnostics industry has started to emerge. Although still a young industry that is only just beginning to find its own identity, it is an area of veterinary medicine that has considerable growth potential.
The US Food and Drug Administration defines a medical device as: "an instrument, apparatus, implement, machine, contrivance, implant, in-vitro reagent, or other similar or related article, including any component, part, or accessory thereof, which is intended for use in the diagnosis of disease or other conditions; in the cure, mitigation, treatment, or prevention of disease in man or other animals; or which is intended to affect the structure or any function of the body of man or other animals. A device does not achieve any of its principle intended purposes through chemical action within or on the body of man or other animals, and is not dependent upon being metabolized for the achievement of any of its principal intended purposes."
For veterinary applications, therapeutic devices (pacemakers, dialysis equipment and so on) are still few and far between. However, the manufacture and sale of diagnosis equipment for veterinary purposes - from hematology analyzers and ELISA tests to ultrasound, X-rays, and MRI - is a significant, growing market.
The industry is still largely unregulated, a fact that is conducive to the creation of new players but creates problems for those who wish to distinguish between what they perceive to be their quality products and cheaper goods, often imports.
In 2006 the first dedicated industry association was formed in Europe to address this kind of issue, but to date there is no similar industry association elsewhere. Firms generally ally themselves with human devices or biotech industry associations, despite having increasingly divergent needs.
The market is an immature one. Worth approximately US$2bn globally, it is dominated by one large company. The rest of the industry is scattered in mostly small and medium-sized firms; the wave of mergers and acquisitions that has happened in the pharmaceutical industry has not yet occurred in this sector.
Some players are divisions of human medical device firms that have discovered veterinary applications for their products, often arising due to demand from vets. A number of firms simply recondition equipment meant for humans, but increasingly equipment is developed intentionally with animals in mind, as companies have seen the potential of a relatively untapped market.
Another common kind of firm operating in this area are offshoots of veterinary laboratories or state research institutes, which originally offered in-house diagnosis and now have discovered markets for products that they can manufacture.
It is still mostly a developed world industry, with the vast majority of companies based in the US, Canada, Europe, Australia and Japan. Large Japanese electronic companies dominate the manufacture of electronic diagnostic equipment such as ultrasound and x-rays.
As with the veterinary pharmaceutical market, there is a sharp division between the livestock and companion animal diagnostic markets. Government control limits the livestock diagnostic market, particularly in Europe, but changing attitudes to pets in affluent countries that have led to a rise in the amount owners are prepared to spend means the potential income from developing sophisticated diagnostic kits and equipment for companion animals is good.
Additionally, although a lot of diagnostic testing is still done at outside reference laboratories, vets' desire to provide better healthcare in-clinic means the uptake of in-clinic tests is likely to increase.
The use of diagnostic tests and equipment is now taught in many veterinary schools and discussed at conferences, and is particularly popular among younger vets - a good omen for the future.
The report examines the various kinds of veterinary diagnostic equipment available - hematology equipment, biochemistry equipment including diagnostic kits, endoscopes, oximeters, vital signs monitors, capnographs, cardiology equipment, MRIs, radiography equipment, diagnostic ultrasound, blood pressure scanners and anaesthesiology equipment. Technically devices can include surgical implements, syringes etc but for the purposes of this survey these will be omitted.
Profiles and contact details of 70 of the leading companies operating in all aspects of the veterinary diagnostic market worldwide are listed. The report analyzes the size and features of the diagnostics market in the context of the overall animal health market, including an examination of market drivers and constraints and regulatory issues. The major regional markets are analyzed in more detail.
The report looks beyond the diagnostic capabilities to examine ways in which these tools can be useful therapeutically, and goes on to reveal the future trends of this emerging market.
Content
- CHAPTER 1 INTRODUCTION
- CHAPTER 2 DEVICES AND DIAGNOSTIC EQUIPMENT
- 2.1 Introduction
- 2.2 Hematology analysis
- 2.2.1 Automated hematology analyzers
- 2.2.2 Coagulation analyzers
- 2.2.3 Blood typing kits
- 2.3 Biochemistry analysis
- 2.3.1 Biochemistry systems
- 2.3.2 Dry chemistry systems
- 2.3.3 Blood gas analyzers
- 2.3.4 Electrolyte analysis
- 2.3.5 Lactate meters
- 2.3.6 Glucose meters
- 2.3.7 Immunoassays
- 2.3.7.1 Competitive immunoassays
- 2.3.7.2 Sandwich immunoassays
- 2.3.7.3 Animal-site rapid immunoassays
- 2.3.8 DNA testing
- 2.3.9 Bile acid tests and others
- 2.3.10 Urine test kits
- 2.3.11 Refractometers
- 2.4 Blood pressure monitors
- 2.5 Pulse oximeters
- 2.5.1 Digital oximeters
- 2.6 Capnography
- 2.7 Vital signs monitors
- 2.8 Anesthesiology equipment
- 2.8.1 Anesthetic machines
- 2.8.1.1 Breathing systems
- 2.8.2 Ventilators
- 2.8.3 Anesthetic agents
- 2.9 Radiography
- 2.9.1 Digital radiography
- 2.9.2 Computed tomography
- 2.9.3 Dental radiography
- 2.9.4 Peripherals and consumables
- 2.10 Diagnostic ultrasound
- 2.10.1 Large animal reproduction
- 2.10.2 Small animal reproduction
- 2.10.3 Equine tendon
- 2.10.4 Cardiology
- 2.10.5 Ophthalmology
- 2.10.6 Ultrasound systems
- 2.10.7 Three dimensional ultrasound
- 2.11 Magnetic resonance imaging
- 2.12 Other imaging
- 2.12.1 Gamma cameras
- 2.12.2 Dermatology imaging
- 2.12.3 PACS
- 2.13 Endoscopes
- 2.13.1 Laparoscopes
- 2.13.2 Tract endoscopes
- 2.13.3 Gastroscopes
- 2.13.4 Bronchoscopes
- 2.13.5 Thoracoscopes
- 2.13.6 Cystoscopes
- 2.13.7 Otoscopes
- 2.13.8 Rhinoscopes
- CHAPTER 3 COMPANY PROFILES
- 3.1 Abaxis
- 3.2 Abbott Laboratories
- 3.3 Adiagene
- 3.4 Agrolabo
- 3.5 ALerCHEK
- 3.6 Aloka
- 3.7 Ampronix
- 3.8 Biogal Galed Laboratories
- 3.9 BioMedica Diagnostics
- 3.10 Biomedica Group
- 3.11 Biovet
- 3.12 Bio Veto Test
- 3.13 BioX Diagnostics
- 3.14 Chembio Diagnostic Systems
- 3.15 Coris Bioconcept
- 3.16 Diatron
- 3.17 Digicare Biomedical Technology
- 3.18 Drew Scientific
- 3.19 Eklin Medical
- 3.20 Esaote
- 3.21 Euroclone
- 3.22 EVL
- 3.23 Fujifilm
- 3.24 GE Healthcare
- 3.25 Genzyme Virotech
- 3.26 Guildhay
- 3.27 Hallmarq Veterinary Imaging
- 3.28 Hemagen Diagnostics
- 3.29 Heska Corporation
- 3.30 Hitachi Medical
- 3.31 Honda Electronics
- 3.32 Hong Kong DNA Chips
- 3.33 IDEXX
- 3.34 Ingenasa
- 3.35 Institut Pourquier
- 3.36 Kruuse
- 3.37 Kyoritsu Seiyaku
- 3.38 Laboratorios Hipra
- 3.39 Makromed
- 3.40 Medison
- 3.41 Medivance (Velopex International)
- 3.42 Medlink Imaging
- 3.43 MegaCor Diagnostik
- 3.44 Melet Schloesing
- 3.45 Midland BioProducts
- 3.46 Mindray
- 3.47 Nonin Medical
- 3.48 PetScreen
- 3.49 Prionics
- 3.50 Qiagen
- 3.51 Richard Wolf
- 3.52 S & B Medvet
- 3.53 Scil Animal Care Company
- 3.54 Sharn Veterinary
- 3.55 Siemens Medical
- 3.56 Summit Industries
- 3.57 Storz
- 3.58 Svanova Biotech
- 3.59 Synbiotics
- 3.60 Sysmex
- 3.61 Thames Medical
- 3.62 Toshiba Medical Systems
- 3.63 TREK Diagnostic Systems
- 3.64 Tridelta
- 3.65 Ultrasound Technologies
- 3.66 United Biomedical
- 3.67 Vet Biotechnology
- 3.68 Vetronic Services
- 3.69 VetSpecs
- 3.70 Viral Antigens
- 3.71 Vita-Tech
- CHAPTER 4 MARKETS
- 4.1 Introduction
- 4.2 Global animal health market
- 4.3 Global diagnostics and devices market
- 4.3.1 Diagnostic and device customers
- 4.3.2 Role of state laboratories
- 4.4 Global animal health industry
- 4.4.1 Animal health industry and diagnostics
- 4.5 Global veterinary devices and diagnostics industry
- 4.6 Global regulation
- 4.6.1 ISO
- 4.6.2 DICOM
- 4.7 Market drivers
- 4.7.1 Growth in companion animal sector
- 4.7.2 Lack of regulation
- 4.7.3 Shift to preventative healthcare
- 4.7.4 Eradication programs
- 4.7.5 Horses
- 4.7.6 Continuing Professional Development
- 4.8 Market constraints
- 4.8.1 Immature market
- 4.8.2 State control
- 4.8.3 Lack of expertise
- 4.8.4 Lack of regulation
- 4.8.5 Decline of livestock industry
- 4.8.6 Unpredictability of disease outbreaks
- 4.8.7 Costs
- 4.9 North America
- 4.9.1 Market features
- 4.9.2 Industry associations
- 4.9.3 Regulation
- 4.9.3.1 Recommendations
- 4.9.3.2 Exceptions
- 4.10 Europe
- 4.10.1 Market features
- 4.10.1.1 Framework Programme 7
- 4.10.2 Industry associations
- 4.10.3 Regulation
- 4.10.3.1 European Physical Agents Directive
- 4.11 Japan/Asia
- 4.11.1 Market features
- 4.11.2 Regulation
- 4.11.3 Other Asia
- CHAPTER 5 THERAPEUTIC AREAS
- 5.1 Major animal diseases and available tools
- 5.1.1 Allergies
- 5.1.2 Avian influenza
- 5.1.3 Bovine tuberculosis
- 5.1.4 Cardiac disease
- 5.1.5 Cancer
- 5.1.6 Cushing's disease
- 5.1.7 Diabetes
- 5.1.8 Feline immunodeficiency virus
- 5.1.9 Foot and mouth disease
- 5.1.10 Heartworm
- 5.1.11 Johne's disease
- 5.1.12 Mycoplasmas
- 5.1.13 Navicular syndrome
- 5.1.14 Parvovirus
- 5.1.15 Transmissible spongiform encephalopathies
- 5.2 Therapeutic areas
- 5.2.1 Endoscopy
- 5.2.1.1 Otoscopy
- 5.2.1.2 Arthroscopy
- 5.2.2 Laparoscopy
- 5.2.2.1 Cryptorchid castration
- 5.2.2.2 Prophylactic gastropexy
- 5.2.2.3 Ovariohysterectomy
- 5.2.2.4 Other laparoscopy
- 5.2.3 Ultrasound
- 5.2.4 Electronic physiotherapy
- 5.2.5 Laser therapy
- 5.2.6 Pacemakers
- 5.2.7 Artificial hips
- CHAPTER 6 FUTURE TRENDS
- 6.1 Livestock trends
- 6.1.1 DNA-based products
- 6.1.2 Food safety
- 6.1.3 Multiple diagnostics
- 6.1.4 Field diagnostics
- 6.2 Companion animals
- 6.2.1 Proteomics
- 6.2.2 Integrated disease management
- 6.2.3 Food allergies
- 6.2.4 Capsule endoscopy
- 6.2.5 Non-invasive devices
- 6.2.6 Nanotechnology
- REFERENCES
- LIST OF TABLES
- Table 2.1 Common reagents used in veterinary biochemistry analyzers
- Table 2.2 Electrolyte imbalances and possible causes in companion animals
- Table 2.3 Diseases that produce microalbuminuria in cats and dogs
- Table 4.1 Geography of the world animal health market, 2004
- Table 4.2 World animal health market by species, 2004
- Table 4.3 Global diagnostics market by region
- Table 4.4 Top 15 veterinary pharmaceutical companies, 2004
- Table 4.5 Top 20 veterinary device and diagnostic firms
- Table 4.6 Regulatory approval needed for major Heska products
- Table 4.7 Pet ownership in the US
- Table 4.8 Sales of veterinary diagnostic products in Japan, million
About this Product
Delivery Details
PDF:Immediate delivery
PRINT/CD-ROM:
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















